Drug Trial Radar · NCT04892706
Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel
Last checked: Nov 20, 2026Latest source record: Oct 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
686
Actual
Start
Jun 11, 2021
Primary completion
Sep 28, 2022
Study completion Sep 28, 2022
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 19, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 99 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The safety and efficacy of once daily application of IDP 126 Gel will be compared to Epiduo® Forte and IDP-126 Vehicle Gel.
Conditions
- Acne Vulgaris
Interventions
IDP-126 GelDrug
Gel applied to face once daily in the evening.
IDP-126 Vehicle GelDrug
Gel applied to face once daily in the evening.
Epiduo® Forte GelDrug
Gel applied to face once daily in the evening.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Change From Baseline to Week 12 in Lesion Counts.Time frame: Baseline to Week 12
- Percentage of Subjects Who Achieve at Least a Two-grade Reduction From Baseline and Are "Clear" or "Almost Clear" at Week 12 in the Evaluator's Global Severity Score.Time frame: Baseline to Week 12
Locations
42 sites in 3 countries. Site status is shown where the registry gives one.
Bausch Site 134
Bryant, Arkansas
Bausch Site 118
Rogers, Arkansas
Bausch Site 110
Fremont, California
Bausch Site 101
Manhattan Beach, California
Bausch Site 106
San Diego, California
Bausch Site 112
San Diego, California
Bausch Site 128
San Diego, California
Bausch Site 105
Boynton Beach, Florida
Bausch Site 126
Clearwater, Florida
Bausch Site 135
North Miami Beach, Florida
Bausch Site 143
Sanford, Florida
Bausch Site 102
Tampa, Florida
Bausch Site 104
West Palm Beach, Florida
Bausch Site 122
West Palm Beach, Florida
Bausch Site 124
Newnan, Georgia
Bausch Site 127
Boise, Idaho
Bausch Site 129
Louisville, Kentucky
Bausch Site 139
Mandeville, Louisiana
Bausch Site 121
Metairie, Louisiana
Bausch Site 116
Rockville, Maryland
Bausch Site 103
Brighton, Massachusetts
Bausch Site 120
New Brighton, Minnesota
Bausch Site 108
Las Vegas, Nevada
Bausch Site 119
New York, New York
Bausch Site 133
New York, New York
Bausch Site 142
High Point, North Carolina
Bausch Site 109
Dublin, Ohio
Bausch Site 117
Oklahoma City, Oklahoma
Bausch Site 107
Gresham, Oregon
Bausch Site 114
Nashville, Tennessee
Bausch Site 111
Austin, Texas
Bausch Site 132
Houston, Texas
Bausch Site 123
Pflugerville, Texas
Bausch Site 137
Spokane, Washington
Bausch Site 136
Kortrijk, Belgium
Bausch Site 140
Maldegem, Belgium
Bausch Site 138
Winnipeg, Manitoba, Canada
Bausch Site 125
Markham, Ontario, Canada
Bausch Site 141
Oakville, Ontario, Canada
Bausch Site 115
Peterborough, Ontario, Canada
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.